Promising FNAIT prevention study halted early after just one participant
Prevention
Terminated
This study tested a drug called RLYB212 in pregnant women at high risk for a condition where the mother's immune system attacks the baby's platelets, causing dangerous bleeding. The goal was to see if the drug was safe and how it moved through the body. Only one woman enrolled be…
Phase: PHASE2 • Sponsor: Rallybio • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC